Similar articles

• Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model.

  Wu KH, Zhou B, Yu CT, Cui B, Lu SH, Han ZC, Liu YL. Wu KH, et al. Ann Thorac Surg. 2007 Apr;83(4):1491-8. doi: 10.1016/j.athoracsur.2006.10.066. Ann Thorac Surg. 2007. PMID: 17383364
• Improvements of cardiac electrophysiologic stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells.

  Zheng S, Zhou C, Weng Y, Huang H, Wu H, Huang J, Wu W, Sun S, Wang J, Tang W, Wang T. Zheng S, et al. Crit Care Med. 2011 May;39(5):1082-8. doi: 10.1097/CCM.0b013e318206d6e8. Crit Care Med. 2011. PMID: 21242796
• Invited commentary.

  Doenst T. Doenst T. Ann Thorac Surg. 2008 Oct;86(4):1249. doi: 10.1016/j.athoracsur.2008.07.041. Ann Thorac Surg. 2008. PMID: 18805170 No abstract available.
• Myocardial repair: from salvage to tissue reconstruction.

  Ruvinov E, Dvir T, Leor J, Cohen S. Ruvinov E, et al. Expert Rev Cardiovasc Ther. 2008 Jun;6(5):669-86. doi: 10.1586/14779072.6.5.669. Expert Rev Cardiovasc Ther. 2008. PMID: 18510484 Review.
• Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".

  Atoui R, Shum-Tim D, Chiu RC. Atoui R, et al. Ann Thorac Surg. 2008 Jul;86(1):327-34. doi: 10.1016/j.athoracsur.2008.03.038. Ann Thorac Surg. 2008. PMID: 18573459 Review.